{"id":"https://openalex.org/W4401190832","doi":"https://doi.org/10.1016/j.slast.2024.100173","title":"A duplexed high-throughput mass spectrometry assay for bifunctional POLB polymerase and lyase activity","display_name":"A duplexed high-throughput mass spectrometry assay for bifunctional POLB polymerase and lyase activity","publication_year":2024,"publication_date":"2024-07-31","ids":{"openalex":"https://openalex.org/W4401190832","doi":"https://doi.org/10.1016/j.slast.2024.100173","pmid":"https://pubmed.ncbi.nlm.nih.gov/39094983"},"language":"en","primary_location":{"id":"doi:10.1016/j.slast.2024.100173","doi":"https://doi.org/10.1016/j.slast.2024.100173","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.slast.2024.100173","pdf_url":null,"source":{"id":"https://openalex.org/S4387277866","display_name":"SLAS TECHNOLOGY","issn_l":"2472-6303","issn":["2472-6303","2472-6311"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-20","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"SLAS Technology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1016/j.slast.2024.100173","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5089903102","display_name":"Zachary A. Gurard\u2010Levin","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210126295","display_name":"Charles River Laboratories (United States)","ror":"https://ror.org/03ndmsg87","country_code":"US","type":"company","lineage":["https://openalex.org/I4210126295"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Zachary A. Gurard-Levin","raw_affiliation_strings":["Charles River Labs, Chicago, IL, USA. Electronic address: Zack.Gurard-Levin@crl.com","Charles River Labs, Chicago, IL, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Charles River Labs, Chicago, IL, USA. Electronic address: Zack.Gurard-Levin@crl.com","institution_ids":["https://openalex.org/I4210126295"]},{"raw_affiliation_string":"Charles River Labs, Chicago, IL, USA","institution_ids":["https://openalex.org/I4210126295"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102914710","display_name":"Brian J. McMillan","orcid":"https://orcid.org/0000-0002-3134-7774","observed_orcids":["https://orcid.org/0000-0002-3134-7774"]},"institutions":[{"id":"https://openalex.org/I4210088252","display_name":"Tango Therapeutics (United States)","ror":"https://ror.org/003x6t567","country_code":"US","type":"company","lineage":["https://openalex.org/I4210088252"]},{"id":"https://openalex.org/I4210105831","display_name":"Jnana Therapeutics (United States)","ror":"https://ror.org/01mvsyt14","country_code":"US","type":"company","lineage":["https://openalex.org/I4210105831"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Brian McMillan","raw_affiliation_strings":["Tango Therapeutics Inc. 901 Brookline Avenue, Suite 901, Boston, MA, 02215, USA; Jnana Therapeutics. One Design Center Place, Suite 19-400, Boston, MA, 02210, USA","Jnana Therapeutics. One Design Center Place, Suite 19-400, Boston, MA, 02210, USA","Tango Therapeutics Inc. 901 Brookline Avenue, Suite 901, Boston, MA, 02215, USA"],"raw_orcid":"https://orcid.org/0000-0002-3134-7774","affiliations":[{"raw_affiliation_string":"Tango Therapeutics Inc. 901 Brookline Avenue, Suite 901, Boston, MA, 02215, USA; Jnana Therapeutics. One Design Center Place, Suite 19-400, Boston, MA, 02210, USA","institution_ids":["https://openalex.org/I4210105831"]},{"raw_affiliation_string":"Jnana Therapeutics. One Design Center Place, Suite 19-400, Boston, MA, 02210, USA","institution_ids":["https://openalex.org/I4210105831"]},{"raw_affiliation_string":"Tango Therapeutics Inc. 901 Brookline Avenue, Suite 901, Boston, MA, 02215, USA","institution_ids":["https://openalex.org/I4210088252"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041017678","display_name":"Douglas A. Whittington","orcid":"https://orcid.org/0000-0002-5946-8543","observed_orcids":["https://orcid.org/0000-0002-5946-8543"]},"institutions":[{"id":"https://openalex.org/I4210088252","display_name":"Tango Therapeutics (United States)","ror":"https://ror.org/003x6t567","country_code":"US","type":"company","lineage":["https://openalex.org/I4210088252"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Douglas A. Whittington","raw_affiliation_strings":["Tango Therapeutics Inc. 901 Brookline Avenue, Suite 901, Boston, MA, 02215, USA"],"raw_orcid":"https://orcid.org/0000-0002-5946-8543","affiliations":[{"raw_affiliation_string":"Tango Therapeutics Inc. 901 Brookline Avenue, Suite 901, Boston, MA, 02215, USA","institution_ids":["https://openalex.org/I4210088252"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003739168","display_name":"Brian Doyon","orcid":"https://orcid.org/0009-0005-8909-0122","observed_orcids":["https://orcid.org/0009-0005-8909-0122"]},"institutions":[{"id":"https://openalex.org/I4210088252","display_name":"Tango Therapeutics (United States)","ror":"https://ror.org/003x6t567","country_code":"US","type":"company","lineage":["https://openalex.org/I4210088252"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Brian Doyon","raw_affiliation_strings":["Tango Therapeutics Inc. 901 Brookline Avenue, Suite 901, Boston, MA, 02215, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Tango Therapeutics Inc. 901 Brookline Avenue, Suite 901, Boston, MA, 02215, USA","institution_ids":["https://openalex.org/I4210088252"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024936309","display_name":"Michael D. Scholle","orcid":"https://orcid.org/0000-0001-8187-1016","observed_orcids":["https://orcid.org/0000-0001-8187-1016"]},"institutions":[{"id":"https://openalex.org/I4210126295","display_name":"Charles River Laboratories (United States)","ror":"https://ror.org/03ndmsg87","country_code":"US","type":"company","lineage":["https://openalex.org/I4210126295"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michael D. Scholle","raw_affiliation_strings":["Charles River Labs, Chicago, IL, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Charles River Labs, Chicago, IL, USA","institution_ids":["https://openalex.org/I4210126295"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090263891","display_name":"Jacques Ermolieff","orcid":"https://orcid.org/0009-0008-5116-5223","observed_orcids":["https://orcid.org/0009-0008-5116-5223"]},"institutions":[{"id":"https://openalex.org/I4210088252","display_name":"Tango Therapeutics (United States)","ror":"https://ror.org/003x6t567","country_code":"US","type":"company","lineage":["https://openalex.org/I4210088252"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jacques Ermolieff","raw_affiliation_strings":["Tango Therapeutics Inc. 901 Brookline Avenue, Suite 901, Boston, MA, 02215, USA; DICE Therapeutics/Lilly, 400 E Jamie CT, Third Floor, South San Francisco, CA, 94080, USA","DICE Therapeutics/Lilly, 400 E Jamie CT, Third Floor, South San Francisco, CA, 94080, USA","Tango Therapeutics Inc. 901 Brookline Avenue, Suite 901, Boston, MA, 02215, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Tango Therapeutics Inc. 901 Brookline Avenue, Suite 901, Boston, MA, 02215, USA; DICE Therapeutics/Lilly, 400 E Jamie CT, Third Floor, South San Francisco, CA, 94080, USA","institution_ids":["https://openalex.org/I4210088252"]},{"raw_affiliation_string":"DICE Therapeutics/Lilly, 400 E Jamie CT, Third Floor, South San Francisco, CA, 94080, USA","institution_ids":[]},{"raw_affiliation_string":"Tango Therapeutics Inc. 901 Brookline Avenue, Suite 901, Boston, MA, 02215, USA","institution_ids":["https://openalex.org/I4210088252"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009873142","display_name":"Madhavi L. Bandi","orcid":"https://orcid.org/0000-0002-7562-0170","observed_orcids":["https://orcid.org/0000-0002-7562-0170"]},"institutions":[{"id":"https://openalex.org/I4210088252","display_name":"Tango Therapeutics (United States)","ror":"https://ror.org/003x6t567","country_code":"US","type":"company","lineage":["https://openalex.org/I4210088252"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Madhavi Bandi","raw_affiliation_strings":["Tango Therapeutics Inc. 901 Brookline Avenue, Suite 901, Boston, MA, 02215, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Tango Therapeutics Inc. 901 Brookline Avenue, Suite 901, Boston, MA, 02215, USA","institution_ids":["https://openalex.org/I4210088252"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020101101","display_name":"Mu\u2010Sen Liu","orcid":"https://orcid.org/0000-0002-3220-9330","observed_orcids":["https://orcid.org/0000-0002-3220-9330"]},"institutions":[{"id":"https://openalex.org/I4210088252","display_name":"Tango Therapeutics (United States)","ror":"https://ror.org/003x6t567","country_code":"US","type":"company","lineage":["https://openalex.org/I4210088252"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mu-Sen Liu","raw_affiliation_strings":["Tango Therapeutics Inc. 901 Brookline Avenue, Suite 901, Boston, MA, 02215, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Tango Therapeutics Inc. 901 Brookline Avenue, Suite 901, Boston, MA, 02215, USA","institution_ids":["https://openalex.org/I4210088252"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Alvaro Amor","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210088252","display_name":"Tango Therapeutics (United States)","ror":"https://ror.org/003x6t567","country_code":"US","type":"company","lineage":["https://openalex.org/I4210088252"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Alvaro Amor","raw_affiliation_strings":["Tango Therapeutics Inc. 901 Brookline Avenue, Suite 901, Boston, MA, 02215, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Tango Therapeutics Inc. 901 Brookline Avenue, Suite 901, Boston, MA, 02215, USA","institution_ids":["https://openalex.org/I4210088252"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5016504937","display_name":"William D. Mallender","orcid":"https://orcid.org/0009-0005-4321-1937","observed_orcids":["https://orcid.org/0009-0005-4321-1937"]},"institutions":[{"id":"https://openalex.org/I4210088252","display_name":"Tango Therapeutics (United States)","ror":"https://ror.org/003x6t567","country_code":"US","type":"company","lineage":["https://openalex.org/I4210088252"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"William D. Mallender","raw_affiliation_strings":["Tango Therapeutics Inc. 901 Brookline Avenue, Suite 901, Boston, MA, 02215, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Tango Therapeutics Inc. 901 Brookline Avenue, Suite 901, Boston, MA, 02215, USA","institution_ids":["https://openalex.org/I4210088252"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5089903102"],"corresponding_institution_ids":["https://openalex.org/I4210126295"],"apc_list":{"value":1800,"currency":"USD","value_usd":1800},"apc_paid":{"value":1800,"currency":"USD","value_usd":1800},"fwci":0.4891,"has_fulltext":false,"cited_by_count":4,"citation_normalized_percentile":{"value":0.46398708,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":96,"max":97},"biblio":{"volume":"29","issue":"5","first_page":"100173","last_page":"100173"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10683","display_name":"Mass Spectrometry Techniques and Applications","score":0.9955999851226807,"subfield":{"id":"https://openalex.org/subfields/1607","display_name":"Spectroscopy"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},"topics":[{"id":"https://openalex.org/T10683","display_name":"Mass Spectrometry Techniques and Applications","score":0.9955999851226807,"subfield":{"id":"https://openalex.org/subfields/1607","display_name":"Spectroscopy"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10519","display_name":"Advanced Proteomics Techniques and Applications","score":0.001500000013038516,"subfield":{"id":"https://openalex.org/subfields/1607","display_name":"Spectroscopy"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10836","display_name":"Metabolomics and Mass Spectrometry Studies","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/dna-polymerase-beta","display_name":"DNA polymerase beta","score":0.7599999904632568},{"id":"https://openalex.org/keywords/polb","display_name":"POLB","score":0.7879999876022339},{"id":"https://openalex.org/keywords/polymerase-activity","display_name":"polymerase activity","score":0.9079999923706055},{"id":"https://openalex.org/keywords/base-excision-repair","display_name":"base excision repair","score":0.949999988079071},{"id":"https://openalex.org/keywords/high-throughput-screening","display_name":"high-throughput screening","score":0.7289999723434448},{"id":"https://openalex.org/keywords/small-molecule-inhibitors","display_name":"small molecule inhibitors","score":0.746999979019165},{"id":"https://openalex.org/keywords/synthetic-lethality","display_name":"synthetic lethality","score":0.7749999761581421},{"id":"https://openalex.org/keywords/parp-inhibitors","display_name":"PARP inhibitors","score":0.9539999961853027},{"id":"https://openalex.org/keywords/brca1-2","display_name":"BRCA1/2","score":0.7170000076293945},{"id":"https://openalex.org/keywords/label-free-binding-assay","display_name":"label-free binding assay","score":0.6800000071525574},{"id":"https://openalex.org/keywords/drug-discovery","display_name":"drug discovery","score":0.43799999356269836}],"concepts":[{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.6334056258201599},{"id":"https://openalex.org/C51323132","wikidata":"https://www.wikidata.org/wiki/Q626251","display_name":"High-throughput screening","level":2,"score":0.5665225982666016},{"id":"https://openalex.org/C82381507","wikidata":"https://www.wikidata.org/wiki/Q416878","display_name":"Polymerase","level":3,"score":0.5209604501724243},{"id":"https://openalex.org/C162356407","wikidata":"https://www.wikidata.org/wiki/Q180809","display_name":"Mass spectrometry","level":2,"score":0.46994784474372864},{"id":"https://openalex.org/C2756471","wikidata":"https://www.wikidata.org/wiki/Q206286","display_name":"DNA polymerase","level":3,"score":0.46656954288482666},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.45148757100105286},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.3365492820739746},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.3225587010383606},{"id":"https://openalex.org/C70721500","wikidata":"https://www.wikidata.org/wiki/Q177005","display_name":"Computational biology","level":1,"score":0.32004523277282715},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.19514209032058716},{"id":"https://openalex.org/C43617362","wikidata":"https://www.wikidata.org/wiki/Q170050","display_name":"Chromatography","level":1,"score":0.191640704870224}],"mesh":[{"descriptor_ui":"D004791","descriptor_name":"Enzyme Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008190","descriptor_name":"Lyases","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D008190","descriptor_name":"Lyases","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D013058","descriptor_name":"Mass Spectrometry","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true},{"descriptor_ui":"D019951","descriptor_name":"DNA Polymerase beta","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D057166","descriptor_name":"High-Throughput Screening Assays","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true}],"locations_count":3,"locations":[{"id":"doi:10.1016/j.slast.2024.100173","doi":"https://doi.org/10.1016/j.slast.2024.100173","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.slast.2024.100173","pdf_url":null,"source":{"id":"https://openalex.org/S4387277866","display_name":"SLAS TECHNOLOGY","issn_l":"2472-6303","issn":["2472-6303","2472-6311"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-20","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"SLAS Technology","raw_type":"journal-article"},{"id":"pmid:39094983","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/39094983","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"SLAS technology","raw_type":"Journal Article"},{"id":"pmh:oai:doaj.org/article:2814a1a1f9b140339aad8d4a13a4a653","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/2814a1a1f9b140339aad8d4a13a4a653","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"SLAS Technology, Vol 29, Iss 5, Pp 100173- (2024)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1016/j.slast.2024.100173","doi":"https://doi.org/10.1016/j.slast.2024.100173","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.slast.2024.100173","pdf_url":null,"source":{"id":"https://openalex.org/S4387277866","display_name":"SLAS TECHNOLOGY","issn_l":"2472-6303","issn":["2472-6303","2472-6311"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-20","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"SLAS Technology","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.5683000087738037}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":42,"referenced_works":["https://openalex.org/W1539508941","https://openalex.org/W1674764723","https://openalex.org/W1709368689","https://openalex.org/W1970574525","https://openalex.org/W1980276118","https://openalex.org/W1980481704","https://openalex.org/W1980900141","https://openalex.org/W1984584014","https://openalex.org/W1991001144","https://openalex.org/W1995250794","https://openalex.org/W1998899327","https://openalex.org/W2011912034","https://openalex.org/W2033245564","https://openalex.org/W2040809710","https://openalex.org/W2055827668","https://openalex.org/W2060444394","https://openalex.org/W2075661561","https://openalex.org/W2092147306","https://openalex.org/W2096647888","https://openalex.org/W2124633033","https://openalex.org/W2125882871","https://openalex.org/W2130233138","https://openalex.org/W2140695271","https://openalex.org/W2151091553","https://openalex.org/W2157867429","https://openalex.org/W2315050993","https://openalex.org/W2327462989","https://openalex.org/W2622715982","https://openalex.org/W2960329758","https://openalex.org/W2978230208","https://openalex.org/W3040835466","https://openalex.org/W3083461972","https://openalex.org/W3121702821","https://openalex.org/W3122533857","https://openalex.org/W3137254564","https://openalex.org/W3152728111","https://openalex.org/W3160581092","https://openalex.org/W3174089752","https://openalex.org/W4220871006","https://openalex.org/W4308951091","https://openalex.org/W4311480785","https://openalex.org/W4399505312"],"related_works":["https://openalex.org/W1999847605","https://openalex.org/W4410130611","https://openalex.org/W4409626959","https://openalex.org/W2895049170","https://openalex.org/W3041532115","https://openalex.org/W1999710641","https://openalex.org/W4399505312","https://openalex.org/W7220850138","https://openalex.org/W2109081379","https://openalex.org/W2022045493"],"abstract_inverted_index":{"Polymerase":[0],"\u03b2":[1],"(POLB),":[2],"with":[3,52],"dual":[4,135],"functionality":[5],"as":[6,57,86],"a":[7,12,58,72,94,116,120,146,169,203],"lyase":[8,40],"and":[9,28,41,78,145,175,201],"polymerase,":[10],"plays":[11],"critical":[13],"role":[14],"in":[15,31,115,155,163,168,198],"the":[16,47,80,100,108,156,164,191],"base":[17],"excision":[18],"repair":[19],"(BER)":[20],"pathway":[21],"to":[22,65,75,106],"maintain":[23],"genomic":[24],"stability.":[25],"POLB":[26,56,87,114,134],"knockout":[27],"rescue":[29],"studies":[30],"BRCA1/2-mutant":[32],"cancer":[33],"cell":[34],"lines":[35],"revealed":[36],"that":[37,88,209],"inhibition":[38],"of":[39,83,113,148,193,206],"polymerase":[42,172],"activity":[43],"is":[44],"required":[45],"for":[46,67,133,141,213],"synthetic":[48],"lethal":[49],"interaction":[50],"observed":[51],"PARP":[53],"inhibitors,":[54],"highlighting":[55],"valuable":[59],"therapeutic":[60],"target.":[61],"Traditional":[62],"biochemical":[63,111],"assays":[64],"screen":[66,105,165],"enzyme":[68],"inhibitors":[69],"focus":[70],"on":[71],"single":[73,117],"substrate":[74],"product":[76],"relationship":[77],"limit":[79],"comprehensive":[81],"analysis":[82],"enzymes":[84],"such":[85],"utilize":[89],"multiple":[90],"substrates":[91],"or":[92],"catalyze":[93],"multi-step":[95],"reaction.":[96],"This":[97,188],"report":[98],"describes":[99],"first":[101],"high-throughput":[102,194,215],"mass":[103,127,185,195],"spectrometry-based":[104],"measure":[107],"two":[109],"distinct":[110],"activities":[112,137],"assay":[118,132,174,180],"using":[119,181],"duplexed":[121,157],"self-assembled":[122],"monolayer":[123],"desorption":[124],"ionization":[125],"(SAMDI)":[126],"spectrometry":[128,186,196],"methodology.":[129],"A":[130],"multiplexed":[131,214],"enzymatic":[136],"was":[138,153],"developed":[139],"optimizing":[140],"kinetically":[142],"balanced":[143],"conditions":[144],"collection":[147],"200,000":[149],"diverse":[150],"small":[151],"molecules":[152],"screened":[154],"format.":[158],"Small":[159],"molecule":[160],"modulators":[161],"identified":[162],"were":[166],"confirmed":[167],"traditional":[170],"fluorescence-based":[171],"strand-displacement":[173],"an":[176],"orthogonal":[177],"label-free":[178],"binding":[179],"SAMDI":[182,207],"affinity":[183],"selection":[184],"(ASMS).":[187],"work":[189],"demonstrates":[190],"flexibility":[192],"approaches":[197],"drug":[199],"discovery":[200],"highlights":[202],"novel":[204],"application":[205],"technology":[208],"opens":[210],"new":[211],"avenues":[212],"screening.":[216]},"counts_by_year":[{"year":2025,"cited_by_count":4}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2024-08-01T00:00:00"}